.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Details for Patent: 8,304,548

« Back to Dashboard

Details for Patent: 8,304,548

Title:Method for producing 1, 2-dihydropyridine-2-one compound
Abstract: The present inventions provide a method for commercially producing a 1,2-dihydropyridine-2-one compound represented by the following formula (III-a) ##STR00001## wherein the ring A represents an optionally substituted 2-pyridyl group, the ring B represents an optionally substituted phenyl group, and the ring C represents an optionally substituted phenyl group. Further, the invention provides crystals of 3-(2-cyanophenyl)-5-(2-pyridyl)-1-phenyl-1,2-dihydropyridin-2-one and production processes therefor.
Inventor(s): Kayano; Akio (Kamisu, JP), Nishiura; Katsutoshi (Kamisu, JP)
Assignee: Eisai R&D Management Co., Ltd. (Tokyo, JP)
Filing Date:Jan 04, 2007
Application Number:11/649,299
Claims:1. A method for producing a compound represented by formula (III): ##STR00021## wherein A.sub.1, A.sub.2, A.sub.3, A.sub.4 and A.sub.5 are as defined below, or a salt thereof, which comprises reacting a compound represented by formula (1): ##STR00022## wherein each of A.sub.1, A.sub.2, A.sub.3 and A.sub.4, which may be the same or different, is a hydrogen atom, an optionally substituted 6- to 14-membered aromatic hydrocarbon ring group or an optionally substituted 5- to 14-membered heteroaromatic ring group, and X is a leaving group, or a salt thereof with a compound represented by formula (II): ##STR00023## wherein A.sub.5 is an optionally substituted 6- to 14-membered aromatic hydrocarbon ring group or an optionally substituted 5- to 14-membered heteroaromatic ring group; and R1 and R2 are as follows: 1) each of R1 and R2, which may be the same or different, is a hydrogen atom or a C1-6 alkyl group, and 2) the compound of formula (II) may form boroxine (a trimer) when both R1 and R2 are hydrogen atoms, or 3) R1, R2, the oxygen atoms and the boron atom, when taken together, form a 5- or 6-membered ring group optionally substituted by one to four C1-6 alkyl groups, in the presence of a palladium compound, a copper compound, a phosphorus compound and a base.

2. A production method according to claim 1, wherein each of A.sub.2 and A.sub.4 is a hydrogen atom.

3. A production method according to claim 1, wherein each of A.sub.1, A.sub.3 and A.sub.5 is a phenyl group, a pyridyl group, a pyrimidyl group, a thienyl group or a furyl group.

4. A production method according to claim 1, wherein a compound represented by formula (III-a): ##STR00024## wherein the ring A, ring B and ring C are as defined below, or a salt thereof is produced by reacting a compound represented by formula (I-a): ##STR00025## wherein the ring A is an optionally substituted 2-pyridyl group, the ring B is an optionally substituted phenyl group, and X is a leaving group, or a salt thereof with a compound represented by formula (II-a): ##STR00026## wherein the ring C is an optionally substituted phenyl group; and R1 and R2 are as follows: 1) each of R1 and R2, which may be the same or different, is a hydrogen atom or a C1-6 alkyl group, and 2) the compound of formula (II-a) may form boroxine (a trimer) when both R1 and R2 are hydrogen atoms, or 3) R1, R2, the oxygen atoms and the boron atom, when taken together, form a 5- or 6-membered ring group optionally substituted by one to four C1-6 alkyl groups, in the presence of a palladium compound, a copper compound, a phosphorus compound and a base.

5. A production method according to claim 4, wherein a compound represented by formula (III-b): ##STR00027## or a salt thereof is produced by reacting a compound represented by formula (I-b): ##STR00028## wherein X is a leaving group, or a salt thereof with a compound represented by formula (II-b): ##STR00029## wherein R1 and R2 are as defined above, in a solvent in the presence of a palladium compound, a copper compound, a phosphorus compound and a base.

6. A production method according to claim 5, wherein the compound (II-b) is a compound represented by formula (II-b-1), formula (II-b-2), formula (II-b-3) or formula (II-b-4): ##STR00030##

7. A production method according to claim 1, wherein X is a halogen atom, an alkylsulfonyloxy group or an arylsulfonyloxy group.

8. A production method according to claim 1, wherein the palladium compound is palladium acetate, palladium chloride or palladium hydroxide.

9. A production method according to claim 1, wherein the phosphorus compound is triphenylphosphine or tri-tert-butylphosphine.

10. A production method according to claim 1, wherein the copper compound is cuprous bromide, cuprous iodide, cuprous chloride or cuprous acetate.

11. A production method according to claim 1, wherein the base is cesium carbonate, sodium carbonate or potassium carbonate.

12. A production method according to claim 1, wherein the copper compound is used in an amount of 0.01 to 0.05 mole per mole of the compound represented by formula (1).

13. A production method according to claim 1, wherein the reaction is carried out in a solvent and 1,2-dimethoxyethane or toluene is used as the solvent for reaction.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc